Novotech is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Novo Nordisk has become one of the most strategically important pharmaceutical companies in the world because of its leadership in diabetes and obesity treatment. The company’s GLP-1 and incretin-based medicines have transformed both its commercial profile and the broader metabolic disease market.

Novavax is a specialist vaccine developer known for protein-based vaccine technology and adjuvant expertise. The company gained global visibility through its COVID-19 vaccine and continues to pursue respiratory vaccine development, including influenza and combination approaches.

Novartis is one of the world’s leading innovative pharmaceutical companies, with a focused strategy around prescription medicines, specialty care, and advanced therapeutic platforms. Following its strategic simplification and separation from non-core businesses, Novartis has increasingly emphasized high-value innovative medicines in areas such as oncology, immunology, neuroscience, cardiovascular disease, and radioligand therapy.

Nkarta is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview

Neurocrine Biosciences is an established biotechnology firm focused on neuroscience, movement disorders, neuroendocrinology, and psychiatric conditions. The company has developed a commercial base while continuing to invest in neurological and psychiatric pipelines.

National Resilience is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

NAMSA is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Moderna is one of the most important mRNA platform companies and a leading developer of next-generation vaccines and immunotherapies. The company’s COVID-19 vaccine validated its mRNA platform at global scale, while its future depends on expanding the platform into respiratory vaccines, personalized cancer vaccines, infectious disease, and broader therapeutic applications.

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany, is a major life science tools and services provider with CDMO capabilities relevant to biologics, viral vectors, process development, and advanced therapeutic manufacturing support.

Merck & Co. remains one of the most important pharmaceutical companies globally, anchored by its oncology leadership, vaccine portfolio, infectious disease expertise, and growing cardiometabolic and specialty medicine activity. Its position has been strongly shaped by Keytruda, one of the world’s most commercially significant oncology medicines.

Medpace is one of the strongest full-service CROs serving biotechnology and pharmaceutical sponsors, with particular strength among small and mid-sized biotech companies. The company is known for its medically led operating model, therapeutic specialization, integrated laboratory and core lab services, and disciplined execution.

Madrigal Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview

Lundbeck is one of the most focused specialty pharmaceutical companies in brain disease, with long-standing activity in psychiatry, neurology, depression, schizophrenia, migraine, Parkinson’s disease, and other central nervous system conditions.

Lonza is one of the world’s leading CDMO providers and a benchmark institution in biomanufacturing. The company supports pharmaceutical and biotechnology sponsors across biologics, small molecules, cell and gene therapy, drug product services, microbial manufacturing, mammalian cell culture, and advanced therapeutic manufacturing.

Legend Biotech is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview

Kyverna Therapeutics is a specialist cell therapy developer focused on autoimmune disease. Its platform applies CAR-T technology to B-cell mediated autoimmune conditions, reflecting one of the most important expansion areas for cellular immunotherapy.

Krystal Biotech is an increasingly important rare disease developer focused on genetic skin diseases and gene therapy. Its approved product Vyjuvek treats dystrophic epidermolysis bullosa, a severe genetic skin disorder, and has given the company a commercial rare disease platform.

Kiniksa Pharmaceuticals is a specialist rare disease company focused on inflammatory and cardiovascular-related orphan conditions. Its flagship product, Arcalyst, is approved for recurrent pericarditis and cryopyrin-associated periodic syndromes, giving the company a focused commercial rare disease platform.

KCR is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview